Elanco finalizes acquisition of Janssen Animal Health
Brussels, Belgium -- Elanco, the animal health division of Eli Lilly and Co., finalized its acquisition of the animal health business of Janssen Pharmaceutica, a Johnson & Johnson company.
Brussels, Belgium
— Elanco, the animal health division of Eli Lilly and Co., finalized its acquisition of the animal health business of Janssen Pharmaceutica, a Johnson & Johnson company.
The acquisition was approved July 7 by the European Commission and will further Elanco’s growth in Europe, according to the company. Elanco says the acquisition will diversify its food-animal portfolio and compliment its companion-animal business.
Terms of the deal have not been disclosed.
Related Content
